English
Back
Open Account
How to view the post-holiday market trend in Hong Kong stocks?
港股窩輪Jenny
joined discussion · Feb 3 11:08

[Warrant Perspective] China Life's medium- and long-term moving averages are biased upwards, while short-term fluctuations await a breakout.

February 2nd,$CHINA LIFE (02628.HK)$
The stock closed at HKD 33.50, representing a 3.96% decline from the previous trading day, with a trading volume of HKD 3.737 billion. The overall trend adjusted in sync with the insurance sector without any abnormal changes in trading volume. From a price positioning perspective, the share price is precisely at the 10-day moving average (HKD 33.50), forming a short-term equilibrium point. Meanwhile, it remains significantly higher than the 30-day moving average (HKD 31.28) and the 60-day moving average (HKD 29.17). The medium- and long-term moving averages still exhibit a weak bullish arrangement, providing some support below.
February 2nd,$CHINA LIFE (02628.HK)$ The stock closed at HKD 33.50, representing a 3.96% decline from the previous trading day, with a trading volume of HKD 3.737 billion. The overall trend adjusted in sync with the insurance sector without any abnormal changes in trading volume. From a price positioning perspective, the share price is precisely at the 10-day moving average (HKD 33.50), forming a short-term equilibrium point. Meanwhile, it remains significantly higher than the 30-day moving average (HKD 31.28) and the 60-day moving average (HKD 29.17). The medium- and long-term moving averages still exhibit a weak bullish arrangement, providing some support below. The RSI indicator is at 60, within the neutral range of 50-70, neither entering overbought territory (≥70) nor reaching oversold levels (≤30). This suggests that the current battle between buyers and sellers is relatively balanced, with no clear dominance by either side. The Williams %R, Stochastic Oscillator, and CCI indicators all provide neutral signals, further confirming the short-term volatile pattern. The MACD signal indicates a buy, but the overall technical indicator summary signal is neutral (signal strength 10), mainly because the short-term adjustment of the individual stock conflicts with the medium- and long-term moving average support, resulting in no clear trend direction for now. Multiple moving average signals indicate a sell, which does not conflict with single moving average support, reflecting that the short-term trend is slightly weak. On February 2, the performance of individual stocks in the insurance sector was generally sluggish, consistent with China Life’s trend, indicating a sector-wide adjustment rather than an isolated weakness in individual stocks: 1、 $CPIC (02601.HK)$ Closed at HKD 38.36, down 2.64%; 2、...
The RSI indicator is at 60, within the neutral range of 50-70, neither entering overbought territory (≥70) nor reaching oversold levels (≤30). This suggests that the current battle between buyers and sellers is relatively balanced, with no clear dominance by either side. The Williams %R, Stochastic Oscillator, and CCI indicators all provide neutral signals, further confirming the short-term volatile pattern. The MACD signal indicates a buy, but the overall technical indicator summary signal is neutral (signal strength 10), mainly because the short-term adjustment of the individual stock conflicts with the medium- and long-term moving average support, resulting in no clear trend direction for now. Multiple moving average signals indicate a sell, which does not conflict with single moving average support, reflecting that the short-term trend is slightly weak.
February 2nd,$CHINA LIFE (02628.HK)$ The stock closed at HKD 33.50, representing a 3.96% decline from the previous trading day, with a trading volume of HKD 3.737 billion. The overall trend adjusted in sync with the insurance sector without any abnormal changes in trading volume. From a price positioning perspective, the share price is precisely at the 10-day moving average (HKD 33.50), forming a short-term equilibrium point. Meanwhile, it remains significantly higher than the 30-day moving average (HKD 31.28) and the 60-day moving average (HKD 29.17). The medium- and long-term moving averages still exhibit a weak bullish arrangement, providing some support below. The RSI indicator is at 60, within the neutral range of 50-70, neither entering overbought territory (≥70) nor reaching oversold levels (≤30). This suggests that the current battle between buyers and sellers is relatively balanced, with no clear dominance by either side. The Williams %R, Stochastic Oscillator, and CCI indicators all provide neutral signals, further confirming the short-term volatile pattern. The MACD signal indicates a buy, but the overall technical indicator summary signal is neutral (signal strength 10), mainly because the short-term adjustment of the individual stock conflicts with the medium- and long-term moving average support, resulting in no clear trend direction for now. Multiple moving average signals indicate a sell, which does not conflict with single moving average support, reflecting that the short-term trend is slightly weak. On February 2, the performance of individual stocks in the insurance sector was generally sluggish, consistent with China Life’s trend, indicating a sector-wide adjustment rather than an isolated weakness in individual stocks: 1、 $CPIC (02601.HK)$ Closed at HKD 38.36, down 2.64%; 2、...
On February 2, the performance of individual stocks in the insurance sector was generally sluggish, consistent with China Life’s trend, indicating a sector-wide adjustment rather than an isolated weakness in individual stocks:
1、 $CPIC (02601.HK)$ Closed at HKD 38.36, down 2.64%;
2、 $PING AN (02318.HK)$ Closed at HKD 70.70, down 2.75%;
3、 $NCI (01336.HK)$ Closed at HKD 61.30, down 3.54%;
4、 $CHINA TAIPING (00966.HK)$ Closed at HKD 24.68, down 3.67%.
From a technical signal perspective, most of these insurance stocks are showing 'neutral' signals, with only China Taiping's RSI reaching 71, triggering a 'sell' signal. The overall sector is under some downward pressure, and market sentiment is relatively cautious.
As of 10:53 AM today (3rd), China Life Insurance's latest price was HKD 33.8, showing a slight increase.The resistance levels are HKD 35.9 (near the recent high) and HKD 36.8 (previous pressure point). For short-term upward movement, the stock price needs to break through HKD 35.9. Key support levels are HKD 31.2 (close to the 30-day moving average with strong support) and HKD 29.7 (previous low, considered a strong support). The 5-day volatility is 11.6%, with a 55% probability of an upward trend, indicating that the short-term price fluctuation range is acceptable, with relatively balanced opportunities for both bulls and bears; neither excessive bullishness nor bearishness is recommended.
Review of Warrants and Product Highlights:
First, let’s review the performance of the previous warrants: On January 27, 2026, four China Life Insurance-related bull warrants were recommended, and after two days, they all showed significant increases, with $UB#CLIFERC2707A.C (56355.HK)$ a rise of 39%, $UBCLIFE@EC2605A.C (22612.HK)$ a rise of 32%, tracking the underlying stock's movement (+4.16%), which aligns with prior technical analysis.
February 2nd,$CHINA LIFE (02628.HK)$ The stock closed at HKD 33.50, representing a 3.96% decline from the previous trading day, with a trading volume of HKD 3.737 billion. The overall trend adjusted in sync with the insurance sector without any abnormal changes in trading volume. From a price positioning perspective, the share price is precisely at the 10-day moving average (HKD 33.50), forming a short-term equilibrium point. Meanwhile, it remains significantly higher than the 30-day moving average (HKD 31.28) and the 60-day moving average (HKD 29.17). The medium- and long-term moving averages still exhibit a weak bullish arrangement, providing some support below. The RSI indicator is at 60, within the neutral range of 50-70, neither entering overbought territory (≥70) nor reaching oversold levels (≤30). This suggests that the current battle between buyers and sellers is relatively balanced, with no clear dominance by either side. The Williams %R, Stochastic Oscillator, and CCI indicators all provide neutral signals, further confirming the short-term volatile pattern. The MACD signal indicates a buy, but the overall technical indicator summary signal is neutral (signal strength 10), mainly because the short-term adjustment of the individual stock conflicts with the medium- and long-term moving average support, resulting in no clear trend direction for now. Multiple moving average signals indicate a sell, which does not conflict with single moving average support, reflecting that the short-term trend is slightly weak. On February 2, the performance of individual stocks in the insurance sector was generally sluggish, consistent with China Life’s trend, indicating a sector-wide adjustment rather than an isolated weakness in individual stocks: 1、 $CPIC (02601.HK)$ Closed at HKD 38.36, down 2.64%; 2、...
Based on the neutral technical outlook for China Life, we have selected two warrant products corresponding to bullish and bearish strategies. Investors can choose according to their own judgment, paying close attention to the rationality of premium and leverage:
1. Bullish Strategy:$JPCLIFE@EC2607B.C (24393.HK)$: Leverage of 5.7, strike price of 39 yuan. The key advantage lies in the lowest premium and implied volatility, offering relatively high cost-effectiveness. Suitable for investors expecting the share price to break through resistance and enter an upward trajectory, with relatively controllable risk.
2. Bearish Strategy:$UB#CLIFERP2805D.P (53039.HK)$: Leverage of 5.2, recovery price of 40 yuan. It has the lowest premium and relatively higher actual leverage, making it suitable for investors expecting the share price to retreat to support levels and weaken in the short term. Note that there is a reasonable gap between the recovery price and the current share price, keeping risks relatively manageable.
February 2nd,$CHINA LIFE (02628.HK)$ The stock closed at HKD 33.50, representing a 3.96% decline from the previous trading day, with a trading volume of HKD 3.737 billion. The overall trend adjusted in sync with the insurance sector without any abnormal changes in trading volume. From a price positioning perspective, the share price is precisely at the 10-day moving average (HKD 33.50), forming a short-term equilibrium point. Meanwhile, it remains significantly higher than the 30-day moving average (HKD 31.28) and the 60-day moving average (HKD 29.17). The medium- and long-term moving averages still exhibit a weak bullish arrangement, providing some support below. The RSI indicator is at 60, within the neutral range of 50-70, neither entering overbought territory (≥70) nor reaching oversold levels (≤30). This suggests that the current battle between buyers and sellers is relatively balanced, with no clear dominance by either side. The Williams %R, Stochastic Oscillator, and CCI indicators all provide neutral signals, further confirming the short-term volatile pattern. The MACD signal indicates a buy, but the overall technical indicator summary signal is neutral (signal strength 10), mainly because the short-term adjustment of the individual stock conflicts with the medium- and long-term moving average support, resulting in no clear trend direction for now. Multiple moving average signals indicate a sell, which does not conflict with single moving average support, reflecting that the short-term trend is slightly weak. On February 2, the performance of individual stocks in the insurance sector was generally sluggish, consistent with China Life’s trend, indicating a sector-wide adjustment rather than an isolated weakness in individual stocks: 1、 $CPIC (02601.HK)$ Closed at HKD 38.36, down 2.64%; 2、...
February 2nd,$CHINA LIFE (02628.HK)$ The stock closed at HKD 33.50, representing a 3.96% decline from the previous trading day, with a trading volume of HKD 3.737 billion. The overall trend adjusted in sync with the insurance sector without any abnormal changes in trading volume. From a price positioning perspective, the share price is precisely at the 10-day moving average (HKD 33.50), forming a short-term equilibrium point. Meanwhile, it remains significantly higher than the 30-day moving average (HKD 31.28) and the 60-day moving average (HKD 29.17). The medium- and long-term moving averages still exhibit a weak bullish arrangement, providing some support below. The RSI indicator is at 60, within the neutral range of 50-70, neither entering overbought territory (≥70) nor reaching oversold levels (≤30). This suggests that the current battle between buyers and sellers is relatively balanced, with no clear dominance by either side. The Williams %R, Stochastic Oscillator, and CCI indicators all provide neutral signals, further confirming the short-term volatile pattern. The MACD signal indicates a buy, but the overall technical indicator summary signal is neutral (signal strength 10), mainly because the short-term adjustment of the individual stock conflicts with the medium- and long-term moving average support, resulting in no clear trend direction for now. Multiple moving average signals indicate a sell, which does not conflict with single moving average support, reflecting that the short-term trend is slightly weak. On February 2, the performance of individual stocks in the insurance sector was generally sluggish, consistent with China Life’s trend, indicating a sector-wide adjustment rather than an isolated weakness in individual stocks: 1、 $CPIC (02601.HK)$ Closed at HKD 38.36, down 2.64%; 2、...
Friendly reminder: Warrants are derivatives with expiration attributes and leverage risks. Investors should consider their risk tolerance, manage positions appropriately, and avoid blindly following trends.
Do you think China Life will first test the resistance at 35.9 or the support at 31.2?
Between the two selected warrants, do you prefer the bullish (24393) or the bearish (53039)?
Come to the comment section and share your thoughts! Want to see more analysis? Remember to follow 'HK Stock Warrants Jenny' for daily updates!
Disclaimer: This article does not constitute any investment advice.
This article is for reference only and does not constitute any investment advice. The market data, opinions, and analysis contained herein may change at any time without prior notice. We are not responsible for any loss or damage caused by reliance on the information in this article. Technical analysis only shows whether certain technical conditions are met; a comprehensive assessment of asset performance should be conducted using additional data. Decisions to trade should not be based solely on this article. Please note that past performance is not indicative of future results.
#HongKongStocks #RealTimeAnalysis #WarrantsSelection #WarrantsStrategy #DerivativesHedging #HongKongWarrantsJenny #ChinaLife #InsuranceSector #TechnicalAnalysis
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Respect
1
Thumbs Up
3
224K Views
Report
Comment (1)
Write a Comment...
1
4